Literature DB >> 11827921

T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Takako Nakajima1, Stephanie Schulte, Kenneth J Warrington, Stephen L Kopecky, Robert L Frye, Jörg J Goronzy, Cornelia M Weyand.   

Abstract

BACKGROUND: CD4 T lymphocytes accumulate in unstable plaque. The direct and indirect involvement of these T cells in tissue injury and plaque instability is not understood. METHODS AND
RESULTS: Gene profiling identified perforin, CD161, and members of the killer-cell immunoglobulin-like receptors as being differentially expressed in CD4(+)CD28(null) T cells, a T-cell subset that preferentially infiltrates unstable plaque. Frequencies of CD161(+) and perforin-expressing CD4 T cells in peripheral blood were significantly increased in patients with unstable angina (UA). CD161 appeared on CD4(+)CD28(null) T cells after stimulation, suggesting spontaneous activation of circulating CD4 T cells in UA. Perforin-expressing CD4(+) T-cell clones from patients with UA exhibited cytotoxic activity against human umbilical vein endothelial cells (HUVECs) in redirected cytotoxicity assays after T-cell receptor triggering and also after stimulation of major histocompatibility complex class I-recognizing killer-cell immunoglobulin-like receptors. HUVEC cytolysis was dependent on granule exocytosis, as demonstrated by the paralyzing effect of pretreating CD4(+)CD28(null) T cells with strontium. Incubation of HUVECs with C-reactive protein (CRP) increased HUVEC lysis in a dose-dependent fashion.
CONCLUSIONS: In patients with UA, CD4 T cells undergo a change in functional profile and acquire cytotoxic capability. Cytotoxic CD4 T cells effectively kill endothelial cells; CRP sensitizes endothelial cells to the cytotoxic process. We propose that T-cell-mediated endothelial cell injury is a novel pathway of tissue damage that contributes to plaque destabilization. The sensitizing effect of CRP suggests synergy between dysregulated T-cell function and acute phase proteins in acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827921     DOI: 10.1161/hc0502.103348

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  98 in total

Review 1.  Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

Review 2.  Inflammation and atherosclerosis.

Authors:  Mehdi H Shishehbor; Deepak L Bhatt
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

Review 3.  Targets of immune regeneration in rheumatoid arthritis.

Authors:  Philipp J Hohensinner; Jörg J Goronzy; Cornelia M Weyand
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

4.  Preferential type 1 chemokine receptors and cytokine production of CD28- T cells in ankylosing spondylitis.

Authors:  C Duftner; C Dejaco; W Kullich; A Klauser; C Goldberger; A Falkenbach; M Schirmer
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

5.  Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina.

Authors:  S Brugaletta; L M Biasucci; M Pinnelli; G Biondi-Zoccai; G Di Giannuario; G Trotta; G Liuzzo; F Crea
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

6.  A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Authors:  Xianghong Chen; Fanqi Bai; Lubomir Sokol; Junmin Zhou; Amy Ren; Jeffrey S Painter; Jinhong Liu; David A Sallman; Y Ann Chen; Jeffrey A Yoder; Julie Y Djeu; Thomas P Loughran; Pearlie K Epling-Burnette; Sheng Wei
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

Review 7.  Rheumatoid arthritis and cardiovascular disease.

Authors:  Cynthia S Crowson; Katherine P Liao; John M Davis; Daniel H Solomon; Eric L Matteson; Keith L Knutson; Mark A Hlatky; Sherine E Gabriel
Journal:  Am Heart J       Date:  2013-08-29       Impact factor: 4.749

8.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.

Authors:  K M J Douglas; A V Pace; G J Treharne; A Saratzis; P Nightingale; N Erb; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

9.  Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.

Authors:  P S Olofsson; L A Söderström; C Jern; A Sirsjö; M Ria; E Sundler; U de Faire; P G Wiklund; J Ohrvik; U Hedin; G Paulsson-Berne; A Hamsten; P Eriksson; G K Hansson
Journal:  J Mol Med (Berl)       Date:  2008-11-08       Impact factor: 4.599

10.  Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.

Authors:  Inés Colmegna; Alejandro Diaz-Borjon; Hiroshi Fujii; Linda Schaefer; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.